{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:36:35Z","timestamp":1792103795157,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013811","name":"Medizinische Fakult\u00e4t, Universit\u00e4t Leipzig","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013811","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mam.2020.100868","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T02:22:09Z","timestamp":1593570129000},"page":"100868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Iron overload and its impact on outcome of patients with hematological diseases"],"prefix":"10.1016","volume":"75","author":[{"given":"Georg-Nikolaus","family":"Franke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sophie","family":"Kubasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladan","family":"Vucinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Platzbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2020.100868_bib1","doi-asserted-by":"crossref","first-page":"19906","DOI":"10.1074\/jbc.M000713200","article-title":"A\u00a0novel mammalian iron-regulated protein involved in intracellular iron metabolism","volume":"275","author":"Abboud","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mam.2020.100868_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/blood-2018-99-111134","article-title":"Safety and efficacy, including event-free survival, of deferasirox versus placebo in iron-overloaded patients with low- and int-1-risk myelodysplastic syndromes (MDS): outcomes from the randomized, double-blind telesto study","volume":"132","author":"Angelucci","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100868_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/ejh.12300","article-title":"Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)","volume":"92","author":"Angelucci","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.mam.2020.100868_bib4","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2018-06-857995","article-title":"Erythroferrone inhibits the induction of hepcidin by BMP6","volume":"132","author":"Arezes","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100868_bib5","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bbmt.2010.09.006","article-title":"Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation","volume":"17","author":"Armand","year":"2011","journal-title":"Biol.Blood Marrow Transplant.: J. Am. Soc. Blood Marrow Transplant."},{"key":"10.1016\/j.mam.2020.100868_bib6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/bmt.2012.94","article-title":"Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT","volume":"48","author":"Armand","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.mam.2020.100868_bib7","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2018-03-784116","article-title":"Chronic immune response dysregulation in MDS pathogenesis","volume":"132","author":"Barreyro","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100868_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.leukres.2014.11.003","article-title":"Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications","volume":"39","author":"Belotti","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mam.2020.100868_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbagen.2011.07.014","article-title":"Non-transferrin bound iron: a key role in iron overload and iron toxicity","volume":"1820","author":"Brissot","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mam.2020.100868_bib10","first-page":"676","article-title":"Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study","volume":"23","author":"Cancado","year":"2018","journal-title":"Hematology (Amsterdam, Netherlands)"},{"key":"10.1016\/j.mam.2020.100868_bib11","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.leukres.2013.07.021","article-title":"A\u00a0comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes","volume":"37","author":"Cermak","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mam.2020.100868_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cmet.2005.10.003","article-title":"Unexpected role of ceruloplasmin in intestinal iron absorption","volume":"2","author":"Cherukuri","year":"2005","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2020.100868_bib13","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/HS9.0000000000000035","article-title":"Erythroferrone","volume":"2","author":"Coffey","year":"2018","journal-title":"HemaSphere"},{"key":"10.1016\/j.mam.2020.100868_bib14","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1080\/10428194.2019.1594215","article-title":"A\u00a0prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation","volume":"60","author":"Cremers","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.mam.2020.100868_bib15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/35001596","article-title":"Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter","volume":"403","author":"Donovan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mam.2020.100868_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.01.003","article-title":"The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis","volume":"1","author":"Donovan","year":"2005","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2020.100868_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/bjh.16156","article-title":"GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1-mediated BMP-SMAD signalling suppression","volume":"188","author":"Fang","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mam.2020.100868_bib18","article-title":"Angiotensin II receptor type 1 blockade prevents arterial remodeling and stiffening in iron overloaded rats","author":"Fidelis","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mam.2020.100868_bib19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.130","article-title":"Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)","volume":"40","author":"Finberg","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mam.2020.100868_bib20","doi-asserted-by":"crossref","first-page":"118535","DOI":"10.1016\/j.bbamcr.2019.118535","article-title":"Iron homeostasis and oxidative stress: an intimate relationship","volume":"1866","author":"Galaris","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.mam.2020.100868_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12185-017-2366-2","article-title":"Iron and infection","volume":"107","author":"Ganz","year":"2018","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.mam.2020.100868_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-4652(199903)178:3<349::AID-JCP9>3.0.CO;2-R","article-title":"Non-transferrin-bound iron uptake in Belgrade and normal rat erythroid cells","volume":"178","author":"Garrick","year":"1999","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.mam.2020.100868_bib23","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.leukres.2010.03.009","article-title":"Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: results from the large 1-year EPIC study","volume":"34","author":"Gattermann","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mam.2020.100868_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.hoc.2017.11.009","article-title":"Ineffective erythropoiesis: anemia and iron overload","volume":"32","author":"Gupta","year":"2018","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.mam.2020.100868_bib25","doi-asserted-by":"crossref","first-page":"10812","DOI":"10.1073\/pnas.96.19.10812","article-title":"Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux","volume":"96","author":"Harris","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mam.2020.100868_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jcp.47.4.350","article-title":"Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy","volume":"47","author":"Harrison","year":"1994","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.mam.2020.100868_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.leukres.2012.11.005","article-title":"Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes","volume":"37","author":"Hartmann","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mam.2020.100868_bib28","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1097\/HS9.0000000000000224","article-title":"Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study","volume":"3","author":"Ho","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.mam.2020.100868_bib29","doi-asserted-by":"crossref","first-page":"106354","DOI":"10.1016\/j.leukres.2020.106354","article-title":"Iron overload regulate the cytokine of mesenchymal stromal cells through ROS\/HIF-1\u03b1 pathway in Myelodysplastic syndromes","volume":"93","author":"Hu","year":"2020","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mam.2020.100868_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/bmt.2015.204","article-title":"Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation","volume":"51","author":"Jaekel","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.mam.2020.100868_bib31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.leukres.2014.06.016","article-title":"Examination of HFE associations with childhood leukemia risk and extension to other iron regulatory genes","volume":"38","author":"Kennedy","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mam.2020.100868_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/intimm\/dxx031","article-title":"Hyperferritinemia and inflammation","volume":"29","author":"Kernan","year":"2017","journal-title":"Int. Immunol."},{"key":"10.1016\/j.mam.2020.100868_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/bmt.2014.273","article-title":"A\u00a0prospective cohort study of the feasibility and efficacy of iron reduction by phlebotomy in recipients of hematopoietic SCT","volume":"50","author":"Kew","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.mam.2020.100868_bib34","first-page":"20","article-title":"The mechanism of erythropoietin action","volume":"18","author":"Koury","year":"1991","journal-title":"Am. J. Kidney Dis. : Off. J. Natl. Kidney Found."},{"key":"10.1016\/j.mam.2020.100868_bib35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/ejh.12674","article-title":"Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase","volume":"96","author":"Latagliata","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.mam.2020.100868_bib36","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.leukres.2009.10.028","article-title":"Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation","volume":"34","author":"Lim","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mam.2020.100868_bib37","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1200\/JCO.2010.34.1222","article-title":"Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome","volume":"30","author":"List","year":"2012","journal-title":"J.\u00a0Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.mam.2020.100868_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10238-019-00592-5","article-title":"Iron chelation therapy for myelodysplastic syndrome: a systematic review and meta-analysis","volume":"20","author":"Liu","year":"2020","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.mam.2020.100868_bib39","first-page":"1588","article-title":"Predicting survival and leukemic evolution in patients with myelodysplastic syndrome","volume":"91","author":"Malcovati","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.mam.2020.100868_bib40","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J.\u00a0Clin. Orthod."},{"key":"10.1016\/j.mam.2020.100868_bib41","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2011.044602","article-title":"Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)","volume":"96","author":"Malcovati","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.mam.2020.100868_bib42","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood-2013-03-492884","article-title":"Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet","volume":"122","author":"Malcovati","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100868_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.leukres.2018.12.001","article-title":"Hepatic and cardiac and iron overload detected by T2\u2217 magnetic resonance (MRI) in patients with myelodisplastic syndrome: a cross-sectional study","volume":"76","author":"Mantovani","year":"2019","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mam.2020.100868_bib44","doi-asserted-by":"crossref","first-page":"116702","DOI":"10.1016\/j.lfs.2019.116702","article-title":"Chronic iron overload intensifies atherosclerosis in apolipoprotein E deficient mice: role of oxidative stress and endothelial dysfunction","volume":"233","author":"Marques","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.mam.2020.100868_bib45","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1089\/ars.2014.6237","article-title":"The interplay between peroxiredoxin-2 and nuclear factor-erythroid 2 is important in limiting oxidative mediated dysfunction in \u03b2-thalassemic erythropoiesis","volume":"23","author":"Matte","year":"2015","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.mam.2020.100868_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/ejh.12476","article-title":"Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: gruppo Romano Mielodisplasie and Registro Basilicata","volume":"95","author":"Maurillo","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.mam.2020.100868_bib47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","article-title":"A\u00a0red carpet for iron metabolism","volume":"168","author":"Muckenthaler","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.mam.2020.100868_bib48","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mam.2020.100868_bib49","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.mam.2020.100868_bib50","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.leukres.2012.04.006","article-title":"Improved survival in MDS patients receiving iron chelation therapy - a matched pair analysis of 188 patients from the D\u00fcsseldorf MDS registry","volume":"36","author":"Neukirchen","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mam.2020.100868_bib51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/ejh.12309","article-title":"The bone marrow hematopoietic microenvironment is impaired in iron-overloaded mice","volume":"93","author":"Okabe","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.mam.2020.100868_bib52","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"Park","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mam.2020.100868_bib53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2141.2006.06273.x","article-title":"Effect of repeated apotransferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation","volume":"135","author":"Parkkinen","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mam.2020.100868_bib54","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/bjh.12368","article-title":"Cardiac iron overload assessed by T2\u2217 magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients","volume":"162","author":"Pascal","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mam.2020.100868_bib55","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/bloodadvances.2019000043","article-title":"Enhanced labile plasma iron in hematopoietic stem cell transplanted patients promotes Aspergillus outgrowth","volume":"3","author":"Petzer","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.mam.2020.100868_bib56","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A\u00a0new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mam.2020.100868_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ejh.13353","article-title":"Allogeneic stem cell transplant in myelodysplastic syndrome-factors impacting survival","volume":"104","author":"Prem","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.mam.2020.100868_bib58","doi-asserted-by":"crossref","first-page":"945289","DOI":"10.1155\/2011\/945289","article-title":"Uptake of non-transferrin iron by erythroid cells","volume":"2011","author":"Prus","year":"2011","journal-title":"Anemia"},{"key":"10.1016\/j.mam.2020.100868_bib59","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/trf.14488","article-title":"Mechanisms of red blood cell transfusion-related immunomodulation","volume":"58","author":"Remy","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.mam.2020.100868_bib60","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3324\/haematol.2014.114827","article-title":"\u03b2-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies","volume":"100","author":"Rivella","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.mam.2020.100868_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood-2018-07-815928","article-title":"Iron metabolism under conditions of ineffective erythropoiesis in \u03b2-thalassemia","volume":"133","author":"Rivella","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100868_bib62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2141.2011.08749.x","article-title":"Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes","volume":"154","author":"Roy","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mam.2020.100868_bib63","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1365-2141.2001.02820.x","article-title":"Non-transferrin-bound iron during allogeneic stem cell transplantation","volume":"113","author":"Sahlstedt","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mam.2020.100868_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023109","article-title":"Hepcidin levels and their determinants in different types of myelodysplastic syndromes","volume":"6","author":"Santini","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.mam.2020.100868_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exphem.2018.10.010","article-title":"Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38- cells through iron chelation, induction of ROS, and inhibition of HIF1\u03b1 expression","volume":"70","author":"Shapira","year":"2019","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.mam.2020.100868_bib66","article-title":"Impact of red blood cell transfusion dose density on progression-free survival in lower-risk myelodysplastic syndromes patients","author":"Swart","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.mam.2020.100868_bib67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12185-011-0988-3","article-title":"The effect of iron overload and chelation on erythroid differentiation","volume":"95","author":"Taoka","year":"2012","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.mam.2020.100868_bib68","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13287-019-1293-y","article-title":"Deferasirox drives ROS-mediated differentiation and induces interferon-stimulated gene expression in human healthy haematopoietic stem\/progenitor cells and in leukemia cells","volume":"10","author":"Tataranni","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.mam.2020.100868_bib69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2015-08-663245","article-title":"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease","volume":"127","author":"Vinchi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100868_bib70","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fphar.2014.00094","article-title":"Atherogenesis and iron: from epidemiology to cellular level","volume":"5","author":"Vinchi","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mam.2020.100868_bib71","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/5979","article-title":"Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse","volume":"21","author":"Vulpe","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mam.2020.100868_bib72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MOH.0000000000000236","article-title":"Hepcidin regulation in the anemia of inflammation","volume":"23","author":"Wang","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.mam.2020.100868_bib73","doi-asserted-by":"crossref","first-page":"633","DOI":"10.17219\/acem\/62397","article-title":"Red blood cell transfusion dependency and hyperferritinemia are associated with impaired survival in patients diagnosed with myelodysplastic syndromes: results from the first polish MDS-PALG registry","volume":"25","author":"Waszczuk-Gajda","year":"2016","journal-title":"Adv. Clin. Exp. Med. : Off. Organ Wroclaw Med. Univ."},{"key":"10.1016\/j.mam.2020.100868_bib74","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1016\/S2352-3026(18)30036-X","article-title":"Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial","volume":"5","author":"Wermke","year":"2018","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.mam.2020.100868_bib75","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1158\/1078-0432.CCR-12-1683","article-title":"MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation","volume":"18","author":"Wermke","year":"2012","journal-title":"Clin. Canc. Res. : Off. J. Am. Assoc. Canc. Res."},{"key":"10.1016\/j.mam.2020.100868_bib76","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1182\/blood.V126.23.2842.2842","article-title":"Comprehensive genomic analysis provides further evidence that iron overload can induce genetic instability in myelodysplastic syndromes","volume":"126","author":"Westhofen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100868_bib77","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V79.11.3007.3007","article-title":"Isolation, characterization, and immunoprecipitation studies of immune complexes from membranes of beta-thalassemic erythrocytes","volume":"79","author":"Yuan","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100868_bib78","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.stem.2016.08.021","article-title":"Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia","volume":"19","author":"Zambetti","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.mam.2020.100868_bib79","first-page":"291","article-title":"Serum ferritin is a different predictor from transfusion history for allogeneic transplantation outcome in patients with severe aplastic anemia","volume":"23","author":"Zhang","year":"2018","journal-title":"Hematology (Amsterdam, Netherlands)"},{"key":"10.1016\/j.mam.2020.100868_bib80","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/hep.25746","article-title":"Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology (Baltimore, Md"}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299720300212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299720300212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:13:13Z","timestamp":1758823993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299720300212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":80,"alternative-id":["S0098299720300212"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2020.100868","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron overload and its impact on outcome of patients with hematological diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2020.100868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100868"}}